Dr. D. CBD

Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Sep
29
2018

Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.

Written by Dr D / CBD, Multiple Sclerosis, THC
Sep
29
2018

Written by Dr D / CBD, Multiple Sclerosis, THC
Neurological Aspects of Medical Use of Cannabidiol.
Sep
22
2018

Neurological Aspects of Medical Use of Cannabidiol.

Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.
May
28
2018

Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.

Nov
22
2017

Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis

Written by Dr D / Multiple Sclerosis
Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.
Nov
22
2017

Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.

An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis.
Nov
22
2017

An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis.

Written by Dr D / Multiple Sclerosis
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis
Nov
22
2017

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis

Written by Dr D / Multiple Sclerosis